Navigating the rapidly changing oncology treatment landscape: how digital tools can help
May 2, 2024 | Access, clinical trials, digital health, digital tools, oncology, patient insight-gathering, reimbursement
With rapid growth comes growing pains…
The field of oncology is rapidly growing and evolving. In 2022, global spending on cancer medicines was approximately 196 billion USD, and this number is forecasted to reach $375 billion by 2027. In fact, for the past five years, the number of treated patients with cancer has seen an average annual increase of 5% globally (1). However, with rapid growth comes growing pains.
Specific challenges facing the oncology field
1. Increased competition and evolving standard of care
New competitors are entering the market at a rapid pace, and competition is intensifying. There are currently more than 2,000 oncology products under development. Emerging biopharma companies are responsible for over 70% of these products (up 20 percentage points from 2017) while Big Pharma has seen a declining share of the oncology pipeline, at only around 20% of products currently under development (down 15 percentage points from 2017). This competitive intensity tends to focus on smaller patient populations with multiple treatment options.
With a larger number of treatable patients, improving survival rates, more clinical trials, and increased focus on real-world evidence, the definition of ‘standard of care’ is continuously changing. As a result, treatment algorithms are becoming more complex, leading to variable uptake and use of new treatments across regions, clinics, and prescribers.
Further, the time advantage traditionally afforded to new cancer therapies has been substantially reduced due to advances in our understanding of the underlying tumor biology and the emergence of novel treatment modalities. Occasionally, the advantage disappears well before the period of exclusivity ends (2)…
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
Capture Tribal Knowledge, Top 10 benefits of virtual advisory boards
We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards. #6. Far Superior Convenience Most KOLs have extremely…
Capture Tribal Knowledge in Advisory Boards
We’re breaking down the benefits of virtual advisory boards, and how they are superior when compared to in-person and hybrid advisory boards. #5. The Ability to Capture “Tribal Knowledge” and…
Create Long-lasting KOL Relationships, benefits of virtual advisory boards
Here’s another top reason why virtual advisory boards are simply better than in-person and hybrid advisory boards. #4. More Frequent Interactions and Long-lasting KOL Relationships Another important benefit of online…
Increased Timeliness for yor Advisory Boards
We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on…
Ten ways to start (or continue) your patient engagement journey
Here are 10 easy approaches Pharma teams can take when starting (or continuing) their patient engagement journey!
Increased Timeliness to Insight-gathering and Output Delivery in Virtual Advisory Boards
We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #3. Increased Timeliness to Insight-gathering and Output Delivery Based on…
Top 10 benefits of virtual advisory boards: Increased Engagement and Insights
#2. Increased Advisor Engagement and Quality and Quantity of Insights
Top 10 benefits of virtual advisory boards: Save Time and Resources
We’ve broken down the top ten benefits of why virtual advisory boards are superior to in-person and hybrid advisory boards. #1. Countless Hours of Time-savings and Substantially Reduced Costs We’ll…
10 Important Advisor Questions: Placement of Your Product in the Current/Future Treatment Algorithm
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…
Top 10 Most Important Advisor Questions: Strengths and Weaknesses of Your Product
As part of our top 10 most important advisor questions that every brand team should keep in mind when designing virtual advisory board touchpoints, here’s another one to keep in…